AlzChem Group AG
XETRA:ACT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
AlzChem Group AG
AlzChem Group AG
Capital Expenditures
AlzChem Group AG
Capital Expenditures Peer Comparison
WCH
EVK
1COV
SY1
UZU
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AlzChem Group AG
XETRA:ACT
|
Capital Expenditures
-€20.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Capital Expenditures
-€834.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Evonik Industries AG
XETRA:EVK
|
Capital Expenditures
-€838m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Covestro AG
XETRA:1COV
|
Capital Expenditures
-€751m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Capital Expenditures
-€270.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
|
|
Uzin Utz AG
XETRA:UZU
|
Capital Expenditures
-€18.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is AlzChem Group AG's Capital Expenditures?
Capital Expenditures
-20.6m
EUR
Based on the financial report for Dec 31, 2023, AlzChem Group AG's Capital Expenditures amounts to -20.6m EUR.
What is AlzChem Group AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
3%
Over the last year, the Capital Expenditures growth was 29%. The average annual Capital Expenditures growth rates for AlzChem Group AG have been 11% over the past three years , 3% over the past five years .
You don't have any saved screeners yet
